未找到相关数据
Molecular subgroup of high-grade serous ovarian cancer (HGSOC) as a predictor of outcome following bevacizumab.
被引：70
作者：
Gourley, Charlie
McCavigan, Andrena
Perren, Timothy
Paul, James
Michie, Caroline Ogilvie
Churchman, Michael
Williams, Alistair
McCluggage, W. Glenn
Parmar, Mahesh
Kaplan, Richard S.
Hill, Laura A.
Haifpenny, Iris A.
O'Brien, Earnonn J.
Raji, Olaide
Deharo, Steve
Davison, Timothy
Johnston, Patrick
Keating, Katherine E.
Harkin, D. Paul
Kennedy, Richard D.
机构：
[1] Edinburgh Canc Res UK Ctr, Edinburgh, Midlothian, Scotland
[2] Almac Diagnost, Craigavon, North Ireland
[3] St James Univ Hosp, St Jamess Inst Oncol, Leeds, W Yorkshire, England
[4] Univ Glasgow, Glasgow, Lanark, Scotland
[5] Ninewells Hosp, Dundee DD1 9SY, Scotland
[6] Univ Edinburgh, Canc Res UK Ctr, Edinburgh, Midlothian, Scotland
[7] Univ Edinburgh, Div Pathol, Edinburgh, Midlothian, Scotland
[8] Belfast Hlth & Social Care Trust, Dept Pathol, Belfast, Antrim, North Ireland
[9] MRC, Clin Trials Unit, London, England
[10] UCL, MRC, Clin Trials Unit, London, England
[11] Queens Univ Belfast, Ctr Canc Res & Cell Biol, Belfast, Antrim, North Ireland
关键词：
D O I：
10.1200/jco.2014.32.15_suppl.5502
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
5502
引用
收藏
页数：1
相关论文